Current Report Filing (8-k)
2013年8月2日 - 5:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
July 31, 2013
Medifast, Inc.
(Exact name of registrant as specified in
its charter)
DE |
|
001-31573 |
|
13-3714405 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
11445 Cronhill Drive, Owings Mills, Maryland |
|
21117 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: 410-581-8042
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02(b) Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers
Effective July 31,
2013, due to health reasons, George J. Lavin, Jr., Esq. resigned as a Director of Medifast, Inc.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
MEDIFAST, INC. |
Dated: August 1, 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Timothy G. Robinson |
|
|
|
|
Timothy G. Robinson |
|
|
|
|
Chief Financial Officer |
Medifast (NYSE:MED)
過去 株価チャート
から 6 2024 まで 7 2024
Medifast (NYSE:MED)
過去 株価チャート
から 7 2023 まで 7 2024